School of nursing and school of public health, Yangzhou University, Yangzhou, Jiangsu, 225000, China.
Department of Operating Room, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200000, China.
BMC Musculoskelet Disord. 2024 Jun 19;25(1):482. doi: 10.1186/s12891-024-07595-8.
The associations between serum uric acid and osteoporosis or osteopenia remain controversial, and few studies have explored whether BMI acts as a mediators in the association between the SUA and OP/ osteopenia.
To explore the relationship between serum uric acid and osteoporosis or osteopenia among US adults.
A cross-sectional study was conducted to examine the association between serum uric acid and osteoporosis or osteopenia from four cycles of NHANES. Binary logistic regression models and restricted cubic spline models were used to evaluate the association between serum uric acid and osteoporosis or osteopenia, and interaction analysis was used to test the differences between subgroups. Mediation analysis was utilized to investigate whether BMI acts as a mediator in the association between SUA and OP/ osteopenia.
12581 participants aged ≥ 18 years were included. A U-shape nonlinear relationship between SUA and osteoporosis or osteopenia in all people was found (P < 0.0001, P for nonlinear = 0.0287). There were significant interactions in age subgroups (P for interaction = 0.044), sex subgroups (P for interaction = 0.005), and BMI subgroups (P for interaction = 0.017). We further assessed the subgroups and found the optimal range of serum uric acid levels with a lower risk of osteoporosis or osteopenia was 357-535 µmol/L in males, 327-417 µmol/L in people aged ≥ 50 years, above 309 µmol/L in people aged < 50 years, 344-445 µmol/L in people with BMI ≥ 30, and above 308 µmol/L in people with BMI < 30. BMI fully mediated the association of SUA and OP/osteopenia, with a value of -0.0024(-0.0026--0.0021). These results were robust in sensitivity analyses.
A complicated relationship between SUA and bone health in different populations was observed. Maintaining SUA within a specific range may be beneficial to bone health. In addition, BMI may play an important role in the association between SUA and bone health, but considering the limitations of this study, further prospective research is required.
血清尿酸与骨质疏松或骨量减少之间的关系仍存在争议,很少有研究探讨 BMI 是否作为 SUA 与 OP/骨量减少之间关联的中介。
探讨美国成年人血清尿酸与骨质疏松或骨量减少之间的关系。
采用横断面研究,从 NHANES 的四个周期中检测血清尿酸与骨质疏松或骨量减少之间的关系。采用二项逻辑回归模型和限制立方样条模型评估血清尿酸与骨质疏松或骨量减少之间的关系,并采用交互分析检验亚组间的差异。采用中介分析探讨 BMI 是否作为 SUA 与 OP/骨量减少之间关联的中介。
共纳入 12581 名年龄≥18 岁的参与者。所有人群中均发现 SUA 与骨质疏松或骨量减少之间呈 U 型非线性关系(P<0.0001,P 非线性=0.0287)。在年龄亚组(P 交互=0.044)、性别亚组(P 交互=0.005)和 BMI 亚组(P 交互=0.017)中存在显著的交互作用。我们进一步评估了亚组,发现男性血清尿酸水平的最佳范围为 357-535μmol/L,≥50 岁人群为 327-417μmol/L,<50 岁人群为高于 309μmol/L,BMI≥30 的人群为 344-445μmol/L,BMI<30 的人群为高于 308μmol/L,这些范围的血清尿酸水平与骨质疏松或骨量减少的风险较低。BMI 完全介导了 SUA 和 OP/骨量减少之间的关联,值为-0.0024(-0.0026--0.0021)。这些结果在敏感性分析中是稳健的。
在不同人群中观察到 SUA 与骨骼健康之间复杂的关系。维持 SUA 在特定范围内可能有益于骨骼健康。此外,BMI 可能在 SUA 与骨骼健康之间的关联中起重要作用,但考虑到本研究的局限性,需要进一步进行前瞻性研究。